ARTES 20th Year Anniversary – a short overview
In 2002 at May 10th Michael Piontek founded ARTES as a one-man operation executing and taking care of two license deals…
In 2002 at May 10th Michael Piontek founded ARTES as a one-man operation executing and taking care of two license deals…
Today, Cellumed Co. Ltd., listed stock market company and Germany based ARTES Biotechnology GmbH announce the execution…
ARTES Biotechnology, the German-based biotech company specializing in process development for recombinant vaccines, ente…
ARTES Biotechnology and Burnet Institute recently published data on the efficient production of malaria vaccine candidat…
ARTES Biotechnology announces the acquisition of the unique SplitCore technology developed by scientists at the Universi…
Under the titel: “ERA-Net EuroTransBio-8: PLURIVAX, development of a virus-like-particle (VLP) based vaccine platform an…
ARTES Biotechnology specialized in microbial process development and technology transfer for pharmaceutical industry is…
ARTES Biotechnology and BioSun Pharmed announced to join forces for the development and manufacturing of a HPV (human pa…
ARTES Biotechnology and Burnet Institute announce they have joined forces to develop a novel, effective vaccine to preve…
ARTES Biotechnology, specialized in microbial cell line and process development for recombinant protein production and t…